Gupta S K, Oppenheim J D, Glick J, Schulman S, Vanderberg J P
Am J Trop Med Hyg. 1985 Sep;34(5):441-6.
There has been controversy whether the plasma protein, alpha 1-acid glycoprotein (AGP), is able to inhibit invasion of erythrocytes by P. falciparum merozoites. Because AGP resembles a typical cell membrane sialoglycoprotein, it has been proposed that it can inhibit the parasite from interacting with its sialoglycoprotein receptor on the erythrocyte surface. We therefore isolated and tested samples of AGP obtained from a series of separate individuals. For comparative purposes, we also tested AGP prepared from the plasma of patients with elevated levels of AGP, as well as AGP obtained from two commercial sources. The authenticity and purity of the AGP samples was established by SDS-PAGE, radial immunodiffusion, and crossed immunoelectrophoresis. Our results indicated that none of the nine samples tested had any significant inhibitory effects in our P. falciparum invasion assay system.
血浆蛋白α1-酸性糖蛋白(AGP)是否能够抑制恶性疟原虫裂殖子侵入红细胞一直存在争议。由于AGP类似于典型的细胞膜唾液酸糖蛋白,有人提出它可以抑制寄生虫与红细胞表面的唾液酸糖蛋白受体相互作用。因此,我们分离并测试了从一系列不同个体获得的AGP样本。为了进行比较,我们还测试了从AGP水平升高的患者血浆中制备的AGP,以及从两个商业来源获得的AGP。通过SDS-PAGE、放射免疫扩散和交叉免疫电泳确定了AGP样本的真实性和纯度。我们的结果表明,在我们的恶性疟原虫侵入测定系统中,所测试的九个样本均没有任何显著的抑制作用。